3 results match your criteria: "Zeenat Qureshi Stroke Institute and University of Missouri[Affiliation]"
Efficacy and safety of argatroban in the management of acute ischemic stroke: A systematic literature review and meta-analysis.
Clin Neurol Neurosurg
January 2024
Zeenat Qureshi Stroke Institute and University of Missouri, Columbia, MO, USA.
Background: Acute ischemic stroke (AIS) is a leading cause of death and disability. AIS is caused by an embolus or thrombus that restricts blood flow to the brain tissue. Despite intravenous thrombolysis and endovascular thrombectomy, a substantial number of patients do not achieve effective reperfusion.
View Article and Find Full Text PDFGeneral Anesthesia Versus Conscious Sedation for Acute Ischemic Stroke Endovascular Therapy: A Meta Analysis of Randomized Controlled Trials.
World Neurosurg
January 2024
Zeenat Qureshi Stroke Institute and University of Missouri, Columbia, Missouri, USA.
Background: Endovascular thrombectomy (E.V.T.
View Article and Find Full Text PDFEarly and mid-term outcomes of carotid angioplasty and stent placement in 579 patients.
J Neuroimaging
November 2022
Zeenat Qureshi Stroke Institute and University of Missouri, Columbia, Missouri, USA.
Article Synopsis
- The study evaluated the incidence and risk factors of early and mid-term complications related to carotid angioplasty and stenting (CAS) in patients with carotid artery stenosis.
- A total of 579 patients were followed for various outcomes after CAS, with primary complications occurring in 2.59% of patients, including strokes, myocardial infarctions, and deaths within the first 30 days.
- Overall survival rates were relatively high, with 93.48% at one year and 77.24% at five years, and risk factors like atrial fibrillation and contralateral carotid artery occlusion were associated with poorer outcomes.